Cantourage Group SE operates within the competitive pharmaceutical sector, specializing in the production and distribution of medical cannabis. Cantourage is known for its accelerated legalization processes that enable the swift access of medical cannabis products across various European markets. The company focuses on streamlining the supply chain, from cultivation to distribution, ensuring that high-quality cannabis reaches patients efficiently and affordably. Through partnerships with a network of cultivators and distributors, Cantourage supports patients' needs by offering a wide range of cannabis varieties, each tailored to specific medical requirements.

Outside of direct product distribution, Cantourage Group SE plays a crucial role in advocating for policy changes and raising awareness about the medicinal benefits of cannabis. As cannabis legalization expands, its involvement in shaping the market's regulatory framework highlights its influence. As a leader in the European medical cannabis space, Cantourage Group SE not only impacts healthcare by providing alternative treatments but also contributes significantly to ongoing legislative and cultural shifts surrounding cannabis usage.